Yuehong Chen

2.7k total citations · 1 hit paper
83 papers, 1.7k citations indexed

About

Yuehong Chen is a scholar working on Molecular Biology, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yuehong Chen has authored 83 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 17 papers in Rheumatology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yuehong Chen's work include SARS-CoV-2 and COVID-19 Research (10 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Gastric Cancer Management and Outcomes (7 papers). Yuehong Chen is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (10 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Gastric Cancer Management and Outcomes (7 papers). Yuehong Chen collaborates with scholars based in China, United States and United Kingdom. Yuehong Chen's co-authors include Shihui Sun, Yusen Zhou, Lanying Du, Lei He, Wanbo Tai, Jian Shang, Jianming Wu, Zheng‐Li Shi, Qibin Geng and Fang Li and has published in prestigious journals such as Molecular Cell, PLoS ONE and Journal of Virology.

In The Last Decade

Yuehong Chen

79 papers receiving 1.7k citations

Hit Papers

Molecular Mechanism for Antibody-Dependent Enhancement of... 2019 2026 2021 2023 2019 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuehong Chen China 21 725 407 331 208 207 83 1.7k
Shuo Li China 19 377 0.5× 436 1.1× 669 2.0× 135 0.6× 194 0.9× 53 1.6k
Roberta Rossi Italy 20 906 1.2× 398 1.0× 236 0.7× 499 2.4× 267 1.3× 75 2.3k
Yu Gong China 16 820 1.1× 168 0.4× 302 0.9× 171 0.8× 152 0.7× 31 1.5k
Silvio Antoniak United States 30 401 0.6× 571 1.4× 478 1.4× 153 0.7× 330 1.6× 66 2.5k
M. Tarek Elghetany United States 22 313 0.4× 382 0.9× 448 1.4× 166 0.8× 196 0.9× 73 1.7k
Ram Doolman Israel 21 746 1.0× 408 1.0× 219 0.7× 89 0.4× 240 1.2× 54 1.8k
Farhan Cyprian Qatar 18 266 0.4× 353 0.9× 340 1.0× 112 0.5× 171 0.8× 42 1.3k
Anthony W.I. Lo Hong Kong 30 772 1.1× 1.0k 2.5× 278 0.8× 239 1.1× 285 1.4× 88 2.9k
Aditya K. Panda India 21 321 0.4× 240 0.6× 394 1.2× 71 0.3× 155 0.7× 99 1.3k

Countries citing papers authored by Yuehong Chen

Since Specialization
Citations

This map shows the geographic impact of Yuehong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuehong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuehong Chen more than expected).

Fields of papers citing papers by Yuehong Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuehong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuehong Chen. The network helps show where Yuehong Chen may publish in the future.

Co-authorship network of co-authors of Yuehong Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yuehong Chen. A scholar is included among the top collaborators of Yuehong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuehong Chen. Yuehong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Junqing, Sen Zhang, Yingde Li, et al.. (2025). Deep learning predicts potential reassortments of avian H5N1 with human influenza viruses. National Science Review. 12(12). nwaf396–nwaf396.
2.
Zhou, Yanan, Li Feng, Jianwei Gao, et al.. (2024). Hierarchical classification for improving parcel-scale crop mapping using time-series Sentinel-1 data. Journal of Environmental Management. 369. 122251–122251. 4 indexed citations
3.
Peng, Yanmei, Wenbo Zheng, Yuehong Chen, et al.. (2024). POLQ inhibition attenuates the stemness and ferroptosis resistance in gastric cancer cells via downregulation of dihydroorotate dehydrogenase. Cell Death and Disease. 15(4). 248–248. 7 indexed citations
4.
Li, Yuchang, Jing Li, Sen Zhang, et al.. (2024). Metabolomic Profiling of Cerebrospinal Fluid Reveals Metabolite Biomarkers in Tick‐Borne Encephalitis Patient. Journal of Medical Virology. 96(11). e70082–e70082. 1 indexed citations
5.
Li, Wei, Yuehong Chen, Feng Ye, et al.. (2023). Generation and Characterization of a Replication-Competent Human Adenovirus Type 55 Encoding EGFP. Viruses. 15(5). 1192–1192. 3 indexed citations
6.
Li, Qianwei, et al.. (2023). Targeting glycolytic pathway in fibroblast-like synoviocytes for rheumatoid arthritis therapy: challenges and opportunities. Inflammation Research. 72(12). 2155–2167. 12 indexed citations
7.
Chen, Yuehong, Huan Liu, Zhongling Luo, et al.. (2023). Fexofenadine protects against lipopolysaccharide-induced acute lung injury by targeting cytosolic phospholipase A2. International Immunopharmacology. 116. 109637–109637. 4 indexed citations
8.
Yang, Jia, Nan Zhu, Ying Chen, et al.. (2023). Tumor-targeting hydroxyapatite nanoparticles for remodeling tumor immune microenvironment (TIME) by activating mitoDNA-pyroptosis pathway in cancer. Journal of Nanobiotechnology. 21(1). 470–470. 22 indexed citations
9.
Chen, Yuehong, et al.. (2022). Neoplasm Risk in Patients With Rheumatoid Arthritis Treated With Fostamatinib: A Systematic Review and Meta-analysis. Frontiers in Pharmacology. 13. 768980–768980. 3 indexed citations
10.
Tang, Ying, Yuchang Li, Sen Zhang, et al.. (2022). Preparation of the luciferase-labeled antibody for improving the detection sensitivity of viral antigen. Virology Journal. 19(1). 126–126. 2 indexed citations
11.
Ma, Wenhui, Yuehong Chen, Wenjun Xiong, et al.. (2021). STOML2 interacts with PHB through activating MAPK signaling pathway to promote colorectal Cancer proliferation. Journal of Experimental & Clinical Cancer Research. 40(1). 359–359. 9 indexed citations
12.
Liu, Zhiwei, Yingluo Liu, Lili Qian, et al.. (2021). A proteomic and phosphoproteomic landscape of KRAS mutant cancers identifies combination therapies. Molecular Cell. 81(19). 4076–4090.e8. 35 indexed citations
13.
Jiang, Yuting, Yuehong Chen, Hong Sun, et al.. (2021). MERS-CoV infection causes brain damage in human DPP4-transgenic mice through complement-mediated inflammation. Journal of General Virology. 102(10). 10 indexed citations
14.
Chen, Yuehong, et al.. (2021). The Cardiovascular Risks of Fostamatinib in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology. 12. 632551–632551. 4 indexed citations
15.
Liu, Huan, et al.. (2021). Therapeutic prospects of MicroRNAs carried by mesenchymal stem cells-derived extracellular vesicles in autoimmune diseases. Life Sciences. 277. 119458–119458. 40 indexed citations
17.
Wan, Yushun, Jian Shang, Shihui Sun, et al.. (2019). Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry. Journal of Virology. 94(5). 462 indexed citations breakdown →
18.
Chen, Yuehong, Ning Shen, Xiaomin Wang, et al.. (2019). EPHA2 feedback activation limits the response to PDEδ inhibition in KRAS-dependent cancer cells. Acta Pharmacologica Sinica. 41(2). 270–277. 7 indexed citations
19.
Chen, Danqi, Yuehong Chen, Fulin Lian, et al.. (2018). Fragment-based drug discovery of triazole inhibitors to block PDEδ-RAS protein-protein interaction. European Journal of Medicinal Chemistry. 163. 597–609. 22 indexed citations
20.
Yi, Tingyu, Wenhuo Chen, Yanmin Wu, et al.. (2017). Special Endovascular Treatment for Acute Large Artery Occlusion Resulting From Atherosclerotic Disease. World Neurosurgery. 103. 65–72. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026